Live Chat

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 74% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Close

Trade Moderna Inc MRNA

Sell
 Buy

Moderna live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2024 Nov 20, 06:40

Analyzing Aligos Therapeutics (NASDAQ:ALGS) and Moderna (NASDAQ:MRNA)

Moderna Inc
Webhose 2024 Nov 19, 13:35

Berenberg Bank Initiates Coverage on Moderna (NASDAQ:MRNA)

Moderna Inc
Webhose 2024 Nov 19, 11:32

Hsbc Global Res Upgrades Moderna (NASDAQ:MRNA) to Strong-Buy

Moderna Inc
Webhose 2024 Nov 19, 09:38

Berenberg sees challenges for Moderna stock—downgrades and visibility issues persist By Investing.com

Moderna Inc
Webhose 2024 Nov 18, 18:18

Moderna (NASDAQ:MRNA) Sees Strong Trading Volume - Here's What Happened

Moderna Inc
Webhose 2024 Nov 18, 17:43

Moderna (NASDAQ:MRNA) Receives "Overweight" Rating from Piper Sandler

Moderna Inc
Webhose 2024 Nov 18, 13:33

Moderna (NASDAQ:MRNA) Raised to Buy at HSBC | MarketBeat

Moderna Inc
Webhose 2024 Nov 18, 13:06

Piper Sandler sees growth potential for Moderna stock despite near-term pressures By Investing.com

Moderna Inc
Webhose 2024 Nov 18, 09:22

KBC Group NV Sells 56,297 Shares of Moderna, Inc. (NASDAQ:MRNA)

Moderna Inc
Webhose 2024 Nov 18, 07:50

Moderna stock climbs as HSBC upgrades to Buy on underestimated pipeline potential By Investing.com

Moderna Inc
Webhose 2024 Nov 18, 06:50

Moderna, Inc. (NASDAQ:MRNA) Receives $90.22 Consensus PT from Analysts

Moderna Inc
Webhose 2024 Nov 18, 05:00

Political Shifts: The Pulse of Pharma Stock Volatility

Moderna Inc
Webhose 2024 Nov 15, 19:05

pfizer stocks: Pfizer and Moderna stocks drop after RFK Jr.'s nomination for Health Secretary: impact on the Pharma Industry - The Economic Times

Moderna Inc
Webhose 2024 Nov 05, 09:26

Moderna CEO Bancel steps down as sales chief, Bloomberg Law reports By Reuters

Moderna Inc

Latest news

Frances Wang 2024 Nov 20, 16:00

MicroStrategy Stock Surges as Bitcoin price rises to fresh record above $94K

Cryptocurrencies
Frances Wang 2024 Nov 20, 16:00

Nasdaq futures decline, Nvidia shares dip following the earnings report

Indices CFD Trading Stocks
Mixed market performance
Neil Wilson 2024 Nov 20, 16:00

Markets Mixed Amid Inflation, Tech Rally, and UK Economic Woes

USD Tech S&P 500
Frances Wang 2024 Nov 19, 16:00

Nvidia shares rallied on AI spending ahead of Nvidia Q3 earnings 2024

NVDA Stocks
Frances Wang 2024 Nov 19, 16:00

Bitcoin price hits record high over $93,800 as Trump rally resumes

Cryptocurrencies
Rising gold prices
Neil Wilson 2024 Nov 19, 16:00

Gold Shines, Bitcoin Surges, and Nvidia Earnings in Focus

Gold Cryptocurrencies
Frances Wang 2024 Nov 18, 16:00

What is the cryptocurrency market doing: Musk's DOGE Role Boosts Dogecoin

Cryptocurrencies
Frances Wang 2024 Nov 18, 16:00

Bitcoin price prediction: BTC May Reach $100K Before New Year

Cryptocurrencies

Info

Spread

0.23

Spread (%)

0.6243 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Thursday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

14215176192

Shares Outstanding

384817984

Earnings Date (Next)

0000-00-00

Div Yield

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-5.81

Learn more about this instrument

Moderna Inc Moderna Inc
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments
Trustpilot
Live Chat